PA
Perceptive Advisors Portfolio holdings
AUM
$3.46B
1-Year Est. Return
112.42%
1 Year Est. Return
+112.42%
AUM
$2.67B
AUM Growth
-$155M
(-5.5%)
Holding
105
Top Buys
| 1 | +$166M | |
| 2 | +$44.4M | |
| 3 | +$37.5M | |
| 4 |
CAI
Caris Life Sciences
CAI
|
+$29.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$19.5M |
Top Sells
| 1 | +$104M | |
| 2 | +$99.9M | |
| 3 | +$90.2M | |
| 4 |
Amicus Therapeutics
FOLD
|
+$80.5M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$42.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Capricor Therapeutics
CAPR
$256M
| – | – |
0
|
|
||
102
Cullinan Oncology
CGEM
$505M
| – | – |
-80,100
|
|
||
|
CRGX
103
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-2,431,085
|
|
||
104
Delcath Systems
DCTH
$315M
| – | – |
-462,422
|
|
||
105
DexCom
DXCM
$22.6B
| – | – |
-178,000
|
|